Press release
Osteoarthritis therapeutics market size Revenue, Growth Opportunities, Competitive Analysis, Trends and Demand by 2026
According to IMARC Group's latest report, titled "Osteoarthritis Therapeutics Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2021-2026", the global osteoarthritis therapeutics market reached a value of nearly US$ 8 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.4% during 2021-2026.We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/osteoarthritis-therapeutics-market/requestsample
Osteoarthritis is a common medical condition that causes pain and swelling in the joints due to the progressive degeneration of cartilage in the knees, hips, hands, feet, spine, shoulders and neck. It results in loss of flexibility and impaired movement in the affected joint, along with stiffness, tenderness, grating sensation and bone spurs. Upon the detection of osteoarthritis via X-ray, arthroscopy, physical examination, joint fluid analysis, blood tests or MRI scans, prescribed medication is generally administered to the patients orally, topically or parenterally. Various physical therapies and alternative medicines can also be used to improve joint function in the affected area.
Market Trends and Drivers:
The global osteoarthritis therapeutics market is majorly driven by the increasing prevalence of osteoarthritis among the masses. Supported by the rising geriatric population that is more susceptible to developing arthritis, there has been an escalating need for efficient osteoarthritis therapeutics across the globe. Apart from this, the rising incidences of obesity on the global level due to unhealthy dietary preferences and the sedentary lifestyles led by individuals have increased the risks of developing osteoarthritis. The market is further driven by a rise in the incidences of injuries and accidents while participating in sports activities. Moreover, continual research and development (R&D) activities conducted by players to launch effective diagnostic and treatment solutions for osteoarthritis and rising government support for introducing novel therapies and pipeline drugs in the market are expected to create a positive outlook for the market. Several players are also aiming to re-grow cartilage using stem cells treated with molecules, which is anticipated to create numerous growth opportunities in the market. Some of the other factors contributing to the market growth include the development of imaging biomarkers based on radiographic features and continual developments to improve the overall healthcare infrastructure.
Osteoarthritis Therapeutics Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global osteoarthritis therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Abbott Laboratories
GlaxoSmithKline Plc
Flexion Therapeutics Inc.
Pfizer Inc.
Anika Therapeutics Inc.
Johnson & Johnson Inc.
Sanofi S.A.
Bayer Aktiengesellschaft
Horizon Therapeutics Plc
Eli Lilly and Company
Key Market Segmentation:
The report has segmented the global osteoarthritis therapeutics market on the basis of anatomy type, drug type, route of administration, end user and region.
Breakup by Anatomy Type:
Knee
Hip
Hand
Spine
Others
Breakup by Drug Type:
Nonsteroidal Anti-Inflammatory Drugs
Analgesics
Corticosteroids
Others
Breakup by Route of Administration:
Parenteral
Topical
Oral
Breakup by End User:
Hospitals
Specialty Clinics
Medical Institutions
Others
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2791&flag=C
Key Highlights of the Report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteoarthritis therapeutics market size Revenue, Growth Opportunities, Competitive Analysis, Trends and Demand by 2026 here
News-ID: 2642361 • Views: โฆ
More Releases from IMARC Group

Saudi Arabia Gaming Market to Reach USD 4,738.5 Million by 2033, Industry Growin โฆ
๐๐๐ฎ๐๐ข ๐๐ซ๐๐๐ข๐ ๐๐๐ฆ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
๐๐๐ฌ๐ ๐๐๐๐ซ: 2024
๐๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐๐๐ฅ ๐๐๐๐ซ๐ฌ: 2019-2024
๐
๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ซ๐ฌ: 2025-2033
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ข๐ง ๐๐๐๐: ๐๐๐ ๐,๐๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง
๐๐๐ซ๐ค๐๐ญ ๐
๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ข๐ง ๐๐๐๐: ๐๐๐ ๐,๐๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ญ๐: ๐.๐% (๐๐๐๐-๐๐๐๐)
The Saudi Arabia gaming market was valued at ๐๐๐ ๐,๐๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2024 and is projected to grow to ๐๐๐ ๐,๐๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2033, with an expected compound annual growth rate (๐๐๐๐) ๐จ๐ ๐.๐% from 2025-2033.
๐๐๐ฎ๐๐ข ๐๐ซ๐๐๐ข๐ ๐๐๐ฆ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The gaming market in Saudiโฆ

UAE Health Insurance Market to Reach USD 14.9 Billion by 2033, Industry Growing โฆ
๐๐๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐๐-๐๐๐๐
โข ๐๐๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ (๐๐๐๐): The UAE health insurance market size reached ๐๐๐ ๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2024.
โข ๐๐๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐
๐จ๐ซ๐๐๐๐ฌ๐ญ (๐๐๐๐): The market is expected to grow to ๐๐๐ ๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2033.
โข ๐๐๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ญ๐: The market is anticipated to exhibit a ๐๐๐๐ ๐จ๐ ๐.๐% during the forecast period from 2025 to 2033.
๐๐๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The market for health insuranceโฆ

Saudi Arabia Health Insurance Market to Reach USD 12.5 Billion by 2033, Industry โฆ
๐๐๐ฎ๐๐ข ๐๐ซ๐๐๐ข๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐๐-๐๐๐๐
According to IMARC Group's report titled "๐๐๐ฎ๐๐ข ๐๐ซ๐๐๐ข๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ฒ ๐๐ฒ๐ฉ๐ (๐๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐๐ฅ, ๐๐ซ๐จ๐ฎ๐ฉ), ๐๐๐ซ๐ฏ๐ข๐๐ ๐๐ซ๐จ๐ฏ๐ข๐๐๐ซ (๐๐ฎ๐๐ฅ๐ข๐, ๐๐ซ๐ข๐ฏ๐๐ญ๐) ๐๐๐๐-๐๐๐๐", the report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.
๐๐จ๐ฐ ๐๐ข๐ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐๐ฎ๐๐ข ๐๐ซ๐๐๐ข๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ?
The Saudi Arabia health insurance market was valued at ๐๐๐ ๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2024 and is projected to growโฆ

UAE Pharmaceutical Market Size Worth USD 8.02 Billion by 2033 | CAGR: 7.30%
๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐๐ซ๐ค๐๐ญ ๐ข๐ง ๐๐๐ ๐๐๐๐:
๐๐จ๐ฐ ๐๐ข๐ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ?
The UAE pharmaceutical market size was valued at ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐. Looking forward, IMARC Group estimates the market to reach ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, exhibiting a CAGR of ๐.๐๐% from 2025-2033.
๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐๐ญ๐ข๐ฌ๐ญ๐ข๐
๐๐๐ฌ๐ ๐๐๐๐ซ: 2024
๐๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐๐๐ฅ ๐๐๐๐ซ๐ฌ: 2019-2024
๐
๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ซ๐ฌ: 2025-2033
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ข๐ง ๐๐๐๐: ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ข๐ง ๐๐๐๐: ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ญ๐ (๐๐๐๐) ๐๐๐๐-๐๐๐๐: ๐.๐๐%
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐
๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐โฆ
More Releases for Osteoarthritis
Osteoarthritis Therapeutics Market: Rising Obese and Geriatric Populations to In โฆ
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
What the Osteoarthritis Therapeutics Market Looks Like?
The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8โฆ
Osteoarthritis Treatment Market by Product (Drugs, Hyaluronic acid Injection) by โฆ
Global Osteoarthritis Treatment Market was valued at USD XX Billion in the year 2017. Global Osteoarthritis Treatment Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023.
Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE369
North America region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At aโฆ
Osteoarthritis-Pipeline Review H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis-Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape.
Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, jointโฆ
Osteoarthritis - Pipeline Review, H2 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape.
Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include olderโฆ
Osteoarthritis - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2017, provides an overview of the Osteoarthritis (Immunology) pipeline landscape.
Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuriesโฆ
Osteoarthritis-Pipeline by Review H2 2017
ReportsWeb.com has announced the addition of the โOsteoarthritis-Pipeline Review H2 2017โ this report provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape.
Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuriesโฆ